Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
8,95 USD | +0,92 % | +29,71 % | +177,09 % |
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Jerel Banks
CEO | Chief Executive Officer | 49 | 01/10/16 |
Peter Roelvink
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/15 |
Megan Boston
CMP | Compliance Officer | 52 | 01/08/16 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
J. Buchi
BRD | Director/Board Member | 69 | 01/04/13 |
Edward Smith
BRD | Director/Board Member | 53 | 14/04/20 |
Peter Francis
BRD | Director/Board Member | 68 | 01/02/06 |
Jerel Banks
CEO | Chief Executive Officer | 49 | 01/10/16 |
Megan Boston
CMP | Compliance Officer | 52 | 01/08/16 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 8 341 586 | 7 472 030 ( 89,58 %) | 0 | 89,58 % |
Información de la empresa
Sector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+177,09 % | 76,07 M | |
+25,69 % | 47,9 mil M | |
+46,90 % | 41,42 mil M | |
-3,46 % | 40,7 mil M | |
-6,20 % | 28,92 mil M | |
+9,17 % | 25,55 mil M | |
-20,42 % | 19,27 mil M | |
+0,17 % | 12,15 mil M | |
+28,07 % | 12,14 mil M | |
-1,24 % | 11,99 mil M |
- Bolsa de valores
- Acciones
- Acción BNTC
- Empresa Benitec Biopharma Inc.